Cargando…
Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center
BACKGROUND: Non-invasive prenatal screening (NIPS) for fetal chromosome abnormalities using cell-free deoxyribonucleic acid (cfDNA) in maternal serum has significantly influenced prenatal diagnosis of fetal aneuploidies since becoming clinically available in the fall of 2011. High sensitivity and sp...
Autores principales: | Neufeld-Kaiser, Whitney A., Cheng, Edith Y., Liu, Yajuan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480508/ https://www.ncbi.nlm.nih.gov/pubmed/26033224 http://dx.doi.org/10.1186/s12916-015-0374-8 |
Ejemplares similares
-
Prenatal Prediction of Outcome by Fetal Gastroschisis in a Tertiary Referral Center
por: Nitzsche, Katharina, et al.
Publicado: (2020) -
Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood
por: Yu, Bin, et al.
Publicado: (2017) -
Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood
por: Zhang, Bin, et al.
Publicado: (2017) -
Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022) -
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)